/genetic type 2 diabetes clinical study in west africa

Ended Definitive Contract Awarded Last action

Contract number
HHSN268201300067C
Awardee
Awarding agency
Obligated
$319,725

Award facts

Opportunity
  • NHLBICSBHG2013306DLM Solicitation number
Contract value 100% obligated
$319,725.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Nigeria

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · Final_close_process -$225
Exercise an Option 4 $79,425
Exercise an Option 3 $0
Exercise an Option 2 · /T2D in west africa $79,650
Exercise an Option 1 $80,550
Original award $80,325

About this award

The National Heart Lung and Blood Institute awarded a $319,725 ceiling-value definitive firm-fixed-price contract to Institute Of Human Virology NIG Ltdgte on September 23, 2013, for a genetic type 2 diabetes clinical study in West Africa, with no set-aside used. Place of performance is Nigeria, and the ultimate completion date is June 5, 2017. The source's status marker indicates the contract is in its final close-out process.

Quick answers

Who was awarded contract HHSN268201300067C?

HHSN268201300067C was awarded to Institute Of Human Virology NIG Ltdgte by National Heart Lung and Blood Institute (National Institutes of Health) on September 23, 2013.

How much is contract HHSN268201300067C worth?

The government has obligated $319,725 on HHSN268201300067C.

Was contract HHSN268201300067C competed?

The extent of competition for HHSN268201300067C was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award